1. Home
  2. GRPN vs NVCR Comparison

GRPN vs NVCR Comparison

Compare GRPN & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Groupon Inc.

GRPN

Groupon Inc.

HOLD

Current Price

$17.83

Market Cap

654.9M

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$12.11

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRPN
NVCR
Founded
2008
2000
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Advertising
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
654.9M
1.3B
IPO Year
2011
2015

Fundamental Metrics

Financial Performance
Metric
GRPN
NVCR
Price
$17.83
$12.11
Analyst Decision
Buy
Buy
Analyst Count
4
6
Target Price
$31.25
$28.42
AVG Volume (30 Days)
1.2M
1.9M
Earning Date
11-06-2025
10-30-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$496,093,000.00
$642,269,000.00
Revenue This Year
$4.17
$9.75
Revenue Next Year
$10.63
$5.62
P/E Ratio
N/A
N/A
Revenue Growth
N/A
11.17
52 Week Low
$9.21
$10.70
52 Week High
$43.08
$34.13

Technical Indicators

Market Signals
Indicator
GRPN
NVCR
Relative Strength Index (RSI) 47.26 50.47
Support Level $16.47 $10.79
Resistance Level $17.08 $11.86
Average True Range (ATR) 0.92 0.59
MACD 0.32 0.06
Stochastic Oscillator 70.34 65.00

Price Performance

Historical Comparison
GRPN
NVCR

About GRPN Groupon Inc.

Groupon Inc acts as the middleman between consumers and merchants, offering products and services at discounts via its online store. It offers consumers daily deals from local merchants. The company's operations are organized into two segments: North America and International. The company generates the majority of its revenue from North America. The company generates revenue from transactions during which the company generates commissions by selling goods or services on behalf of third-party merchants. Revenue also includes commissions the company earn when customers make purchases with retailers using digital coupons accessed through its digital properties.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

Share on Social Networks: